SCHAUMBURG, Ill., Sept. 30, 2011 (CRWENewswire) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced U.S. FDA approval of Clindamycin Injection, USP, an antibiotic used to treat bacterial infections. Sagent’s latex-free clindamycin will be available in three single-dose vial sizes and in pharmacy bulk packaging. According to IMS, the 2011 U.S. market for injectable clindamycin approximates $65 [...]